Discover 1,726 paid clinical trials in High Point, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,726
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
for
Ovarian Neoplasms, Fallopian Tube Neoplasms,
Location: Durham NC, Lexington KY, Atlanta GA, Baltimore MD,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07213804
Phase3, Recruiting
A Study of a Decision Tool for People Considering Breast Reconstruction Surgery
for
Breast Cancer
Location: Durham NC, Basking Ridge NJ, Middletown NJ, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT07335354
Recruiting
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
for
Large B-cell Lymphoma, Lymphoma, B-Cell,
Location: Durham NC, Norfolk VA, Atlanta GA, Cincinnati OH,
Sponsor: Lyell Immunopharma, Inc.
Sex: All
Age: 18+
Code: NCT07188558
Phase3, Recruiting
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
for
Multiple Myeloma (MM)
Location: Durham NC, Atlanta GA, Baltimore MD, Louisville KY,
Sponsor: C4 Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07280013
Phase1, Recruiting
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: Durham NC, New York NY, Sarasota FL, Boston MA,
Sponsor: Bristol-Myers Squibb
Sex: Male
Age: 18+
Code: NCT06067841
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer
for
Relapsed/Refractory Small Cell Lung Cancer
Location: Durham NC, Nashville TN, Cleveland OH, Detroit MI,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07325136
Phase1, Phase2, Recruiting
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
for
Ovarian Neoplasms, Ovarian Cancer
Location: Durham NC, Norfolk VA, Knoxville TN, Fairfax VA,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT07318558
Phase3, Recruiting
Family Building Decision Support for Female Adolescent and Young Adult Cancer Survivors
for
Cancer Survivorship, Family Planning,
Location: Durham NC
Sponsor: Duke University
Sex: Female
Age: 18 - 39
Code: NCT07471685
Recruiting
Trans-Rectal Ultrasound of the Female Pelvis for Real-Time MRI-US Fusion Based Needle Tracking
for
Uterine Cancer
Location: Durham NC
Sponsor: Duke University
Sex: Female
Age: 18 - 70+
Code: NCT05977621
Recruiting
A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.
for
Colorectal Cancer
Location: Durham NC, Pittsburgh PA, Florida City FL,
Sponsor: Kahr Bio Australia Pty Ltd
Sex: All
Age: 18+
Code: NCT07235293
Phase2, Recruiting
A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)
for
Sarcoma,Soft Tissue
Location: Durham NC, Columbus OH, Philadelphia PA,
Sponsor: Intensity Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06263231
Phase3, Recruiting
A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors
for
Hematopoietic Stem Cell Transplant
Location: Durham NC, Tampa FL, Boston MA
Sponsor: Brigham and Women's Hospital
Sex: All
Age: 18+
Code: NCT06328127
Recruiting
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
for
NSCLC (Advanced Non-small Cell Lung Cancer)
Location: Durham NC, Fairfax VA, Washington D.C. DC,
Sponsor: BlossomHill Therapeutics
Sex: All
Age: 18+
Code: NCT06706076
Phase1, Phase2, Recruiting
KM3D Multicenter Cancer Consortium: Predicting Patient Response Using 3D Cell Culture Models
for
Cancer, Predictive Cancer Model, Effects of Chemotherapy
Location: Durham NC, Rochester MN, Houston TX
Sponsor: Known Medicine, Inc.
Sex: All
Age: 18+
Code: NCT05338073
Recruiting
Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology
for
Cancer, Prostate Cancer
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT07463833
Recruiting
REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors
for
Ovarian Cancer, Advanced Ovarian Carcinoma,
Location: Durham NC, Boston MA, Aurora CO, Boulder CO
Sponsor: Dana-Farber Cancer Institute
Sex: Female
Age: 18+
Code: NCT06710548
Recruiting
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
for
High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer,
Location: Durham NC, Chesapeake VA, Fairfax VA, Atlanta GA,
Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Sex: Female
Age: 18+
Code: NCT05128825
Phase2, Recruiting
Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors
for
Brain Tumor, Primary, Brain Metastases, Adult
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT05480644
Recruiting
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
for
Metastatic HER2-positive Breast Cancer
Location: Durham NC, Morrisville NC, Roanoke VA, Asheville NC,